SCHEMBL4312397

SCHEMBL4312397

O=C1c2ccc(O)cc2CCN1C1CCCN(Cc2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 3/20 0.49
ACHE P22303 2/20 0.49
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
GRM5 P41594 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
OPRM1 P35372 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2B Q13224 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
CHRM2 P08172 2/20 0.41
PRMT5 O14744 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4312395 1.00 CHRM3 (0.49) CHRM3ACHEALDH1A1KDM4ETDP1
SCHEMBL3655701 0.94 ACHE (0.53) CHRM3ACHEGRM5OPRM1GRIN1
SCHEMBL3655702 0.94 ACHE (0.53) CHRM3ACHEGRM5OPRM1GRIN1
SCHEMBL3660506 0.87 ACHE (0.55) CHRM3ACHEALDH1A1KDM4EGRM5
SCHEMBL3653205 0.85 DRD2 (0.56) CHRM3ACHESIGMAR1MEN1KMT2A
SCHEMBL3653206 0.85 DRD2 (0.56) CHRM3ACHESIGMAR1MEN1KMT2A
SCHEMBL3559821 0.83 ACHE (0.47) ACHEOPRM1GRIN1GRIN2BSIGMAR1
SCHEMBL3559826 0.83 ACHE (0.47) ACHEOPRM1GRIN1GRIN2BSIGMAR1
SCHEMBL3653318 0.82 DRD2 (0.47) CHRM3ACHESIGMAR1
SCHEMBL3653314 0.82 DRD2 (0.47) CHRM3ACHESIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069370-A1 AZACYCLYLISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS WYETH (US) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069370-A1 AZACYCLYLISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS HRH4, HRH1, HRH2 CHRM3 114/4885ACHE 377/4885ALDH1A1 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.